iBALT from COPD and IPF patients include IgA+ B cells, a feature that correlates with increased levels of circulating IgA autoantibodies directed against KRT18 and KRT19 (in COPD) or citrullinated proteins (in IPF). This evidence concerns the gene CD79A and chronic obstructive pulmonary disease.